Skip to content

analgesic Effect of clozapine in Abdominal surgery

Effect of clozapine as apreemptive analgesia in Patients Undergoing Abdominal Hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201806003461321
Enrollment
60
Registered
2018-06-12
Start date
2018-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Fertility-female abdominal hysterectomy surgeries

Interventions

clozapine group
control group

Sponsors

suez canal university hospital
Lead Sponsor
departemnt of anesthesia ,faculty of medicine ,suez canal university
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1-Adults more than 21 years and less than 60 years of age undergoing abdominal hystrectomy 2-Patients are ASA I (American Society of Anesthesiologists physical status Grade I) = (normal healthy patients), ASA II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations) 3-Abdominal hysterectomy under general anesthesia 4-Patients of Body Mass Index (BMI) ¿ 20 and ¿ 30

Exclusion criteria

Exclusion criteria: 1-Refusal of participation in the study 2-A known history of sensitivity to clozapine 3-Schizophrenia or other psychiatric disorder (a previous diagnosis of any psychiatric disorder listed in Diagnostic and Statistical Manual of Mental Disorders IV), history of untreated non-psychotic emotional disorders, cognitive impairment or any difficulties with communication that will impair or interfere with Peri-operative and assessment procedures 4-History of drug dependency or substance addiction

Design outcomes

Primary

MeasureTime frame
intraoperative analgesic requirements

Secondary

MeasureTime frame
preoperative sedation using Riker Sedation-Agitation Scale;heart rate;mean arterial blood pressure;duration of surgery from skin incision to skin closure;Total intraoperative mean isoflurane consumption;postoperative recovery using modified Aldrete score;post-perative sedation using Riker Sedation-Agitation Scale;Time of first analgesic request;24 hours morphine consumption by PCA;Adverse effects: dizziness, insomnia, unresponsiveness, agitation, airway obstruction, respiratory depression, or nausea and vomiting;postoperative VAS score at rest;postoperative VAS score at movement

Countries

Egypt

Contacts

Public Contactmohamed abuelnaga

lecturer of anesthesia and intensive care ,faculty of medicine ,suez canal university

Mohamed_abuelnga@med.suez.edu.eg002-01004150671

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026